Benign Prostate Hyperplasia Clinical Trial
Official title:
Addition of Lidocaine to Levobupivacaine Reduces Intrathecal Block Duration: Randomized Controlled Trial
Verified date | December 2012 |
Source | Diskapi Teaching and Research Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | Turkey: Ethics Committee |
Study type | Interventional |
The main objective was to test the hypothesis that adding lidocaine to hyperbaric levobupivacaine could change the duration of levobupivacaine spinal block.
Status | Completed |
Enrollment | 40 |
Est. completion date | July 2011 |
Est. primary completion date | July 2011 |
Accepts healthy volunteers | No |
Gender | Male |
Age group | 40 Years to 80 Years |
Eligibility |
Inclusion Criteria: - elective transurethral resection of the prostate (TUR-P) Exclusion Criteria: - patients with contraindications for spinal anesthesia, - known sensitivity to the study drugs, - emergency cases, and - patients who refused spinal anaesthesia were excluded |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Turkey | Ankara Diskapi Yildirim Beyazit Teaching and Research Hospital | Ankara |
Lead Sponsor | Collaborator |
---|---|
Diskapi Teaching and Research Hospital |
Turkey,
Lee SJ, Bai SJ, Lee JS, Kim WO, Shin YS, Lee KY. The duration of intrathecal bupivacaine mixed with lidocaine. Anesth Analg. 2008 Sep;107(3):824-7. doi: 10.1213/ane.0b013e3181806149. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | maximum block level | the dermatomal level that the sensorial block reached, determined with the pin prick test, expressed with dermatomes | participants will be followed on the operation day | No |
Primary | The duration of the spinal block (S1 regression of the block) | the time between the intrathecal injection and sensorial block regression to S1 dermatome, measured in minutes | participanta will be followed on the operation day | No |
Secondary | postoperative care unit stay | the time between the patient entered the PACU and left the PACU (when the sensorial block was regressed to S1 dermatome and the patient fulfilled an Aldrete score higher or equal to 9), measured in minutes | participants will be followed on the operation day | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01942551 -
Safety and Pharmacokinetic Interaction Study of Tadalafil and Dutasteride
|
Phase 1 | |
Completed |
NCT01436877 -
Assessing Safety & Efficacy of MediTate Temporary Implant in Subjects With Benign Prostate Hyperplasia
|
N/A | |
Completed |
NCT02822924 -
Prostate Artery Embolization for Symptomatic Benign Prostatic Hyperplasia
|
N/A | |
Completed |
NCT02390882 -
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HGP0412 and HIP1402 in Patients With BPH
|
Phase 3 | |
Completed |
NCT02839122 -
A Study to Investigate the Pharmacokinetic Drug Interactions Between Dutasteride and Tadalafil in Healthy Male Subjects
|
Phase 1 | |
Not yet recruiting |
NCT01861041 -
Low Dose Bupivacaine Spinal for Trans Uretral Prostatectomy.
|
Phase 4 | |
Completed |
NCT02332538 -
HoLEP vs. Greenlight 532nm-laser PVEP vs. Bipolar TURP in Management of Moderate/ Large BPH
|
N/A | |
Completed |
NCT01835860 -
Prostatic Artery Embolization for Benign Prostatic Hyperplasia
|
Phase 2/Phase 3 | |
Completed |
NCT01665586 -
Effective Dose of Dexmedetomidine for Sedation in Patients Undergoing TURP/TURB Under Spinal Anesthesia With or Without Fentanyl by Age Groups: Randomized Comparative Study
|
N/A | |
Completed |
NCT02038868 -
A Study to Evaluate the Efficacy and Safety of ASP4901 in Patients With Benign Prostate Hyperplasia
|
Phase 2 | |
Completed |
NCT02506465 -
Pivotal Study to Assess the Safety and Effectiveness of the iTind Device
|
N/A | |
Completed |
NCT02483819 -
Changes of the Hemodynamic Profiles on Bio Reactance Technique During TURP in Elderly Patients
|
N/A | |
Recruiting |
NCT02827578 -
Efficacy and Safety of Tamsulosin/Solifenacin Combination Therapy in Patients With Voiding Symptoms and Moderate to Severe Storage Symptoms Due to Benign Prostate Hyperplasia
|
Phase 3 | |
Completed |
NCT02352311 -
Safety and Pharmacokinetic Characteristics of DKF-313
|
Phase 1 | |
Completed |
NCT01627522 -
Evaluation of Finastride Effect in Different Dosage on the Amount of Perioperative Bleeding in Transurthral Resection of Prostate
|
Phase 2/Phase 3 | |
Completed |
NCT01494337 -
Holmium Laser Enucleation of Prostate(HOLEP) vs Greenlight(XPS) Laser Photoselective Vapo-Enucleation of Prostate(PVEP)
|
Phase 4 | |
Completed |
NCT01952912 -
Plasmakinetic Enucleation of the Prostate and Open Prostatectomy to Treat Large Prostates
|
N/A | |
Active, not recruiting |
NCT01736033 -
Advanced Benefits of Alpha-blocker Monotherapy on Lower Urinary Tracts Symptoms(LUTS) Patients
|
Phase 4 | |
Recruiting |
NCT02021032 -
Post-Marketing Study Using PROLIEVE® for the Treatment of Benign Prostatic Hyperplasia (BPH)
|
Phase 4 | |
Completed |
NCT00861588 -
Effects of Isoflavone in Patients With Watchful Waiting Benign Prostate Hyperplasia
|
N/A |